Mirae Asset Global Investments Co., Ltd.

Position in CCCC — C4 Therapeutics, Inc.

CIK 1569395 SEOUL, M5

Position in CCCC

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$23,093

+$9,707 QoQ

Shares Held

4,945

-2.8% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#130

of 147 holders

Holding Since

Jun 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. CCCC ranks #160 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,093	4,945	-2.8%	Shares	Sole	2026-07-22
2026-03-31	$13,386	5,090	+8.1%	Shares	Sole	2026-05-04
2025-12-31	$8,994	4,709	+71.2%	Shares	Sole	2026-01-26
2025-09-30	$6,107	2,751	+0.3%	Shares	Sole	2025-11-03
2025-06-30	$3,922	2,743	+15.5%	Shares	Sole	2025-07-21
2025-03-31	$3,800	2,375	+1.0%	Shares	Sole	2025-04-24
2024-12-31	$8,467	2,352	-94.3%	Shares	Sole	2025-01-27
2024-03-31	$338,604	41,445	+137.3%	Shares	Defined	2024-05-01
2023-03-31	$54,845	17,467	-0.2%	Shares	Defined	2023-05-04
2022-12-31	$103,226	17,496	+0.1%	Shares	Sole	2023-02-09
2022-09-30	$153,281	17,478	-21.0%	Shares	Sole	2022-11-10
2022-06-30	$166,776	22,119	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.